TickerHumSide-by-side comparison
Boston Scientific vs Stryker
As of Nov 11, 2026, P/E is 19.0x for Boston Scientific vs 33.9x for Stryker; P/S is 3.1x for Boston Scientific vs 4.6x for Stryker; revenue growth is 8.9% for Boston Scientific vs 7.9% for Stryker; operating margin is 18.7% for Boston Scientific vs 20.7% for Stryker.
What stands out
- Boston Scientific is cheaper on earnings: 19.0x P/E vs 33.9x for Stryker.
- Stryker's shares did better over the past year: -13.2% vs -56.7% for Boston Scientific.
- Stryker scores higher on TickerHum's ratings: 59/100 vs 49/100 for Boston Scientific.
Key metrics
| Metric | BSX | SYK |
|---|---|---|
| Price | $45.13 | $318.79 |
| Market cap | $65.41B | $121.36B |
| P/E | 19.0x (#1) | 33.9x (#2) |
| P/S | 3.1x (#1) | 4.6x (#2) |
| Revenue growth | 8.9% (#1) | 7.9% (#2) |
| Operating margin | 18.7% (#2) | 20.7% (#1) |
| Net margin | 16.6% (#1) | 13.8% (#2) |
| Debt / equity | 0.43 (#1) | 0.60 (#2) |
| 1-year return | -56.7% (#2) | -13.2% (#1) |
| Research score | 49/100 (#2) | 59/100 (#1) |
Higher is better for growth, margins, one-year return and overall score; lower is better for valuation and debt ratios. Ties share a rank and missing values are excluded.
Company research
- Boston Scientific Corporation (BSX) — Medical Devices
- Stryker Corporation (SYK) — Medical Devices